Digital natives: are pharma companies ready?

As evolving technologies and societal changes drive the use of digital channels and media, health and life sciences companies face the challenging task of engaging ‘digitally native’ healthcare professionals, patients, and other key stakeholders.

These ‘customers’ have an inherent understanding of technology and expect companies to adopt new ways of interacting. However, while life science companies have been quick to invest in digital communications, leveraging the full potential of evolving technologies requires companies to make a conscious commitment to the customer experience in an increasingly digital world. 

In this evolving landscape, companies must be proactive, favouring active digital enlightenment over passive digital adoption, to accelerate lasting change that supports customer engagement and the broader healthcare landscape.

Join us on Friday 10th March at 9:30 ET/14:30 GMT/15:30 CET for a roundtable discussion as panellists from Healthware Group, EVERSANA INTOUCH and Grünenthal Group explore what it takes to thrive as a digitally enlightened company, including challenging existing business ethos, and identifying and deploying digital approaches to deliver content that engages customers effectively and drives value.

The webinar will also cover:

• How a customer-centric strategy can help cut through the noise of digital communication
• Applying technology on customers’ terms to add value to the user experience 
• Creating a foundation of modular content blocks to deliver agile communications materials

Attendees will leave with a clearer understanding of how to maximise the potential of digital healthcare communication and key insights to help professionals move beyond the digital native myth towards true digital enlightenment. 

About the panel 

Florent Edouard is the global head of commercial excellence at Grünenthal Group, a pharmaceutical company headquartered in Germany and specialised in pain. Coming from AstraZeneca where he led multiple commercial functions including four years in charge of the AZ Respiratory and GI franchise in Japan, he joined Grünenthal in 2017 to drive the company’s commercial transformation, from launch excellence to field team impact, through analytics uplift as well as platform and capability build across affiliates. He is enthusiastic about what he refers to as the “complete revolution” being experienced by healthcare, which will usher in new treatments, new technologies and new mindsets and values. Florent has served in various roles within the healthcare industry for almost 20 years and is MIT-certified in digital marketing analytics and digital business strategy.

Ariel Salmang is chief growth officer, Healthware Group and managing director, EVERSANA INTOUCH International. Ariel has 25+ years of providing impactful digital strategies and implementation across multiple industries, from media and FMCG to telecommunications and healthcare, where he has spent the last decade focusing on the digital evolution of pharma companies and the creation of impactful digital brand and sales drivers. 

Dr Paul Tunnah is managing director, Healthware International. He is an entrepreneur who founded the industry-leading publication pharmaphorum, as well as a recognised author, speaker, moderator, and industry advisor who is passionate about helping organisations tell authentic stories that resonate and unlock the power of digital and social media in connecting with stakeholders.